Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Zauderer Maurice Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 Zauderer Maurice (President and CEO) has filed a Form 4 on VACCINEX, INC.
Txns: Bought 500,000 shares @ $1, valued at $500k
Bought 5,000 shares @ $0.93, valued at $4.7k
Bought 5,000 shares @ $0.973, valued at $4.9k
Bought 500,000 warrants @ $1, valued at $500k
04/03/2023 4 Zauderer Maurice (President and CEO) has filed a Form 4 on VACCINEX, INC.
Txns: Granted 731,707 shares @ $0.41, valued at $300k
Granted 56,000 options to buy @ $0.4395, valued at $24.6k
12/07/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/04/2022 4 Zauderer Maurice (President and CEO) has filed a Form 4 on VACCINEX, INC.
Txns: Granted 28,000 options to buy @ $1.29, valued at $36.1k
01/31/2022 4 Zauderer Maurice (President and CEO) has filed a Form 4 on VACCINEX, INC.
Txns: Bought 1,801,801 shares @ $1.11, valued at $2M
04/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/26/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
01/27/2020 4 Zauderer Maurice (President and CEO) has filed a Form 4 on VACCINEX, INC.
Txns: Bought 98,231 shares @ $5.09, valued at $500k
07/31/2019 4 Zauderer Maurice (President and CEO) has filed a Form 4 on VACCINEX, INC.
Txns: Bought 183,824 shares @ $4.08, valued at $750k
03/19/2019 4 Zauderer Maurice (President and CEO) has filed a Form 4 on VACCINEX, INC.
Txns: Granted 20,000 options to buy @ $4.29, valued at $85.8k
08/15/2018 4 Zauderer Maurice (President and CEO) has filed a Form 4 on VACCINEX, INC.
Txns: Converted 93,547 shares @ $0
Converted 95,448 shares @ $0
Converted 815,698 shares @ $0
Converted 569,993 convertible preferred @ $0
Converted 581,577 convertible preferred @ $0
Converted 8,157,067 convertible preferred @ $0

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy